Production of ES1 Plasma Carboxylesterase Knockout Mice for Toxicity Studies
Citations Over TimeTop 10% of 2011 papers
Abstract
The LD(50) for soman is 10-20-fold higher for a mouse than a human. The difference in susceptibility is attributed to the presence of carboxylesterase in mouse but not in human plasma. Our goal was to make a mouse lacking plasma carboxylesterase. We used homologous recombination to inactivate the carboxylesterase ES1 gene on mouse chromosome 8 by deleting exon 5 and by introducing a frame shift for amino acids translated from exons 6 to 13. ES1-/- mice have no detectable carboxylesterase activity in plasma but have normal carboxylesterase activity in tissues. Homozygous ES1-/- mice and wild-type littermates were tested for response to a nerve agent model compound (soman coumarin) at 3 mg/kg sc. This dose intoxicated both genotypes but was lethal only to ES1-/- mice. This demonstrated that plasma carboxylesterase protects against a relatively high toxicity organophosphorus compound. The ES1-/- mouse should be an appropriate model for testing highly toxic nerve agents and for evaluating protection strategies against the toxicity of nerve agents.
Related Papers
- → Toxicology and pharmacology of bispyridinium oximes insight into the mechanism of action vs Soman poisoning in vivo(1981)147 cited
- → Species differences in the in vitro inhibition of brain acetylcholinesterase and carboxylesterase by mipafox, paraoxon, and soman(1986)14 cited
- → Study of Efficacy of Reactivator HI-6 in Reactivation of Immobilized Acetylcholinesterase, Inhibited by Organophosphorus Chemical Warfare Agents of the “G” Series(2009)3 cited
- → Differences in the Toxicity of Soman in Various Strains of Mice(1981)1 cited
- Effects of diacetylmonoxime and HI-6 on soman clearance from blood in rats(2001)